Volumina Medical, developing novel biomaterials for dermatology and plastic surgery, closed its Series A round by existing and new investors. It will enable the medtech company to advance clinical program with its lead product Adipearl after having obtained promising First in Human Data, and ultimately achieve market approval in key international markets..

Volumina Medical正在开发用于皮肤病学和整形外科的新型生物材料，并在现有和新投资者的支持下结束了其A轮系列。它将使medtech公司在获得有希望的第一次人体数据后，利用其领先产品Adiparl推进临床计划，并最终在关键的国际市场获得市场认可。

Adipearl is an innovative injectable dermal filler enabling the regeneration of soft tissues. The product addresses the need of millions of patients that require the reconstruction or regeneration of tissues after surgery, disease or for aesthetic purposes. The product is currently being used in clinical trials by world-renowned key opinion leaders in Europe..

Adiparl是一种创新的可注射真皮填充剂，可促进软组织再生。该产品满足了数百万患者在手术、疾病或美学目的后需要重建或再生组织的需求。该产品目前正被欧洲世界著名的关键意见领袖用于临床试验。

Volumina Medical will use the funding gather additional and valuable clinical data to bring Adipearl to the market and ultimately help millions of patients that currently lack natural and durable solutions for improving their health and wellbeing.

Volumina Medical将利用这笔资金收集更多有价值的临床数据，将Adiparl推向市场，并最终帮助数百万目前缺乏改善健康和福祉的天然持久解决方案的患者。

“I will never forget the intensity of the smiles on face of the first patients that were treated with Adipearl. Together with this funding round it is providing us a lot of confidence and an extremely high energy to continue to develop Volumina Medical and offer our solution to millions of patients”, said Amélie Béduer, CEO and CO-Founder of Volumina..

Volumina首席执行官兼联合创始人艾米丽·贝杜尔（Amélie Béduer）表示：“我永远不会忘记首批接受Adiparl治疗的患者脸上笑容的强烈程度。这一轮融资为我们提供了很大的信心和极高的活力，可以继续开发Volumina Medical并为数百万患者提供解决方案。

Each year, millions of patients suffer from the loss of soft tissue volume, for example: muscles, adipose tissues, glandular tissues. Soft tissue loss may occur from trauma, tumor ablation, or simply aging processes. The loss of soft tissue is frequently permanent and causes disfiguring tissue depression, which can not only have an impact cosmetically, but also functionally..

每年，数百万患者遭受软组织体积的损失，例如：肌肉，脂肪组织，腺体组织。创伤，肿瘤消融或简单的衰老过程可能会导致软组织丢失。软组织的损失通常是永久性的，会导致组织凹陷，这不仅会对美容产生影响，还会对功能产生影响。

Volumina Medical offers a potential alternative to current treatment methods through the development of a regenerative medicine approach where a biomaterial scaffold facilitates tissue regeneration in the defect area, enabling minimally invasive repair of 3D volumes in a single injection session.

Volumina Medical通过开发再生医学方法提供了当前治疗方法的潜在替代方案，其中生物材料支架促进缺损区域的组织再生，从而能够在单次注射过程中微创修复3D体积。